Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from Revision: v3.6.0 to Revision: v3.6.3, reflecting a small platform update to the study detail page.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:49.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer seeking participants. The page now includes guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a standardized 'Intervention/Treatment' label, alongside a revision note 'Revision: v3.6.0' and removal of the previous 'Revision: v3.5.5' version.
    Difference
    0.3%
    Check dated 2026-06-15T18:49:15.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision label updated to v3.5.5, signaling a backend or CMS update rather than a change to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-08T15:50:15.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a behind-the-scenes update to the page or system. The study content and user-facing information appear unchanged.
    Difference
    0.0%
    Check dated 2026-05-18T03:53:29.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Updates the site footer revision/version label from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:17:39.000Z thumbnail image
  7. Check
    104 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. This update does not modify the study content or details.
    Difference
    0.0%
    Check dated 2026-03-21T07:56:18.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.